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Background
Allergic reactions to drugs are often unpredictable and can
lead to serious side effects such as anaphylactic shock.
According to the hapten hypothesis, any drug with a mole-
cular weight lower than 1000 daltons cannot induce an
immune response by itself and must be bound to a pro-
tein. Antigen presenting cells, such as dendritic cells (DC),
internalize hapten-protein conjugates and digest them into
peptides bound with the drug. The latter are then pre-
sented on HLA molecules to drug-specific T cells inducing
specific-drug immune response. Knowing that drugs pro-
voke IgE mediated hypersensitivity reactions in treated
patients, the CD4+ T-cell response to benzylpenicillin
(BP) was investigated. The objectives of this study were to
evaluate the frequency of naïve CD4+ T cells specific to
BP and to identify BP-haptenized peptides responsible for
T lymphocyte activation.
Method
Since BP is known to bind covalently to proteins, such as
Human Serum Albumin (HSA), HSA-BP bio-conjugates
were synthesized at basic pH (pH=10.8). Seventeen BP
binding-sites on HSA were then identified using mass-
spectrometry, and 12 BP-haptenized peptides of 15 mer
long potentially presented to T-cells via HLA class II
molecules were identified and synthetized. Naïve CD4+
T cells from non-allergic donors were stimulated once a
week with autologous DC loaded with HSA-BP or with
peptide-BP to amplify respectively HSA-BP- or peptide-
BP-specific T cells. Activation of specific CD4+ T cells
was detected using interferon- EliSpot and their frequency
was calculated using the Poisson distribution law.
Results
The results of the CD4+ T-cell response to BP were as
follows:
- Detection of HSA-BP-specific CD4+ T cells in 12
out of 13 tested donors with a mean frequency of 0.26
cells/million of circulating CD4+ T cells
- Identification of 17 binding sites of BP on HSA
- Specific naïve CD4+ T cells recognized at least 3
specific peptides, from HSA, haptenized by BP.
Conclusion
This study showed the capacity of HSA-BP to be recog-
nized by naïve T-cells from multiple healthy donors
irrespective of their HLA typing and the possibility to
identify BP-haptenized peptides involved in the allergic
reaction to BP.
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